Stockreport

Graft Versus Host Disease (GvHD) Treatment Market Analysis, 2018-2023 and 2024-2030: Corticosteroids, Hospitals, and North America Will Dominate During the Forecast Period [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF The graft versus host disease treatment market is expected to grow with a CAGR of 8.6% from 2024 to 2030. The major drivers for this market are increasing demand for pe [Read more]